- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.07. | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | 218 | GlobeNewswire (Europe) | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen | |
| 23.07. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | Incannex receives U.S. patent for sleep apnea drug IHL-42X | 2 | Investing.com | ||
| 25.06. | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | 553 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| 25.06. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.06. | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | 474 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 09.06. | Incannex Healthcare: Incannex Announces Initiation of Research Coverage by Alliance Global Partners | 319 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Incannex Healthcare Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | Incannex launches DReAMzz study for sleep apnea treatment | 2 | Investing.com | ||
| 14.05. | Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | 578 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for... ► Artikel lesen | |
| 12.05. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 22.04. | Incannex begrüßt US-Erlass zur Beschleunigung von Therapien für psychische Erkrankungen | 1 | Investing.com Deutsch | ||
| 22.04. | Incannex supports White House order on mental health treatments | 4 | Investing.com | ||
| 22.04. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 27.03. | Incannex reaktiviert Aktienrückkaufprogramm nach Phase der Inaktivität | 2 | Investing.com Deutsch | ||
| 27.03. | Incannex resumes share buyback after period of inactivity | 1 | Investing.com | ||
| 27.03. | Incannex Healthcare: Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position | 1 | GlobeNewswire (USA) | ||
| 25.03. | Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research | 2 | GlobeNewswire (USA) | ||
| 25.03. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,570 | -0,29 % | Turnaround-Aktien mit fast 200 % Kurspotenzial! Renk, Eckert & Ziegler, Power Metallic Mines! | Rund 50 % hat die Renk-Aktie seit Oktober 2025 verloren. Ist jetzt die Chance zum Einstieg gekommen? Jefferies sieht den fairen Wert immerhin bei 60 EUR. Die kommenden Halbjahreszahlen sollten überzeugen... ► Artikel lesen | |
| MCKESSON | 740,60 | -0,30 % | McKesson's Compounding Keeps Adding Up | ||
| HEALWELL AI | 0,415 | +2,22 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,220 | +1,55 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| SENSEONICS | 4,180 | -0,95 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| IMUNON | 1,450 | +4,32 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,584 | +2,95 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-a-NET in GEP-NETs | European orphan medicinal product designation granted for [212Pb]VMT-a-NET for the treatment of GEP-NETs[212Pb]VMT-a-NET is being evaluated in an ongoing Phase 1/2a study in patients with SSTR2-positive... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 44,200 | +1,38 % | Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors | MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive... ► Artikel lesen | |
| INSPIREMD | 0,580 | +1,75 % | InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,290 | -1,16 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,866 | -0,12 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,700 | +1,79 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| INTELLIGENT BIO SOLUTIONS | 1,850 | +2,21 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 5,890 | +1.406 % | Lexaria Bioscience Corp.: Lexaria Announces Effective Date for Reverse Stock Split | KELOWNA, BC / ACCESS Newswire / July 30, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it intends to effect... ► Artikel lesen | |
| GLUCOTRACK | 0,459 | -3,79 % | Glucotrack, Inc. - 8-K, Current Report |
Das Unternehmen INCANNEX HEALTHCARE INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,060 Euro und damit +4,08 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INCANNEX HEALTHCARE INC finden Sie auf Wallstreet Online.